Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blinded Prospective Randomized Controlled Trial Comparing Cefazolin Plus Vancomycin Versus Cefazolin Plus Daptomycin for Vascular Surgery Prophylaxis

NCT01612052 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.

NCT NCT01612052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01612052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blinded Prospective Randomized Controlled Trial Comparing Cefazolin Plus Vancomycin Versus Cefazolin Plus Daptomycin for Vascular Surgery Prophylaxis
Lead sponsor
CAMC Health System
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2011
Completion date
October 31, 2013
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mrsa - methicillin resistant staphylococcus aureus infection